-
-
-
-
-
-
-
AcelRx Pharma (ACRX) Confirms FDA Advisory Committee Recommends Approval of DSUVIA for Treatment of Moderate-To-Severe Acute Pain
-
-
-
-
-
-
-
AcelRx Pharma (ACRX) Announces Date of FDA Advisory Committee Meeting for DSUVIA
-
-
-
-
-
-
-
AcelRx Pharmaceuticals to Present at Jefferies 2017 Global Healthcare Conference
-
-
-
-
-
-
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

